Throughout his distinguished 42-year career in dentistry, Dr. Timothy Pfister, D.M.D. has fine-tuned his focus on providing ...

UK biotechnology company SolasCure has commenced the randomised, controlled CLEANVLU2 Phase II trial of Aurase Wound Gel for ...

In the coming years, more people are going to be spending money on non-invasive treatments, especially K-Beauty facial ...

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today ...

In 2023 the Wallace H. Coulter Department of Biomedical Engineering launched a new program designed to train the next ...

An inquest has been opened at Norfolk Coroner's Court after day-old Thiyash Thajeepan died at the James Paget Hospital.

SolasCure, a Cambridge biotech developing a novel treatment to transform chronic wound healing, has initiated a new Phase II ...

Genentech’s label expansion for TNKase consolidates its market position for pharmacological stroke treatments.

This work describes a novel set of clot analogs to represent a diverse range of fibrin and red blood cell (RBC) compositions for use in acute ischemic stroke (AIS) occlusion models. Method Fresh whole ...